Tetanus: A review

Southern Medical Journal

Volumn 104, Issue 8, 2011, Pages 613-617

  Ataro, Peter ^a   Mushatt, David ^a   Ahsan, Shagufta ^a  

^a NONE

Author keywords

tetanospasmin; tetanus; toxoid; trismus

Indexed keywords

ANTITOXIN; CLINDAMYCIN; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; ERYTHROMYCIN; IMMUNOGLOBULIN G; METRONIDAZOLE; PENICILLIN G; TETANUS ANTIBODY; TETANUS TOXOID;

ADVERSE OUTCOME; BACTERIUM IDENTIFICATION; CLINICAL FEATURE; CLOSTRIDIUM TETANI; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG HALF LIFE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LABORATORY TEST; MORTALITY; NONHUMAN; OPTIMAL DRUG DOSE; PATHOPHYSIOLOGY; REVIEW; TETANUS; TETANUS PROPHYLAXIS; WOUND CARE;

DIAGNOSIS, DIFFERENTIAL; HUMANS; TETANUS; VACCINATION;

EID: 80051543056     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e318224006d     Document Type: Review

References (38)

1. Centers for Disease Control and Prevention tetanus surveillanceVUnited States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011;60:365-369.
2. Hsu S, Groleau G. Tetanus in the emergency department: a current review. J Emerg Med 2001;20:357-365. (Pubitemid 32448009)
3. Biological products. Bacterial vaccines and toxoids; implementation of efficacy review; proposed rule. Fed Regist 1985;50:51002-51117.
4. Simonsen O, Bentzon M, Heron I. ELISA for the routine determination of antitoxic immunity to tetanus. J Biol Stand 1986;14:231-239. (Pubitemid 16018387)
5. Borrow R, Balmer P, Roper MH. Tetanus update 2006. In: Immunization, Vaccines and Biologicals (Immunological Basis for Immunization Series; Module 3). Geneva: World Health Organization; 2006: 1-35.
6. Tetanus: questions and answers information about the disease and vaccines: immunization Action Coalition. St Paul, MN. Available at: www.vaccineinformation.org; www.immunize.org. Accessed April 20, 2011.
7. Bardenheier B, Prevots DR, Khetsuriani N, et al. Tetanus surveillanceV United States, 1995-1997. CDC surveillance summaries (July 3). MMWR Morb Mortal Wkly Rep 1998;47(no. SS-2):1-13. (Pubitemid 128463643)
8. Centers for Disease Control and Prevention. Tetanus surveillanceV United States, 1998-2000. MMWR Morb Mortal Wkly Rep 2003; 52(SS03);1-8.
9. Backer EL, Gregory P, Jaén CR, et al. A closer look at adult female health care maintenance visits. Fam Med 2006;38:355-360. (Pubitemid 43723600)
10. Nowalk MP, Zimmerman RK, Cleary SM, et al. Missed opportunities to vaccinate older adults in primary care. J Am Board Fam Pract 2005;18: 20-27. (Pubitemid 41657632)
11. Tetanus cases in US from 1947-2005. In: Tetanus and Tetanus Toxoid: Epidemiology and Prevention of Vaccine-Preventable Diseases. Atlanta, GA: National Immunization Program Centers for Disease Control and Prevention, 2006.
12. Talan DA, Abrahamian FM, Moran GJ, et al. Tetanus immunity and physician compliance with tetanus prophylaxis practices among emergency department patients presenting with wounds. Ann Emerg Med 2004;43: 305-314. (Pubitemid 38282639)
13. Mandell GL, Bennett JE, Dolin R. Mandell. Douglas and Bennett's Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, PA, Churchill Livingstone/Elsevier, 2010.
14. Bleck TP, Brauner JS. Tetanus. In: Scheld WM, Whitely RJ, Durack DT, eds. Infections of the Central Nervous System. 2nd ed. Philadelphia, PA, Lippincott-Raven, 1997:629-653.
15. Schwartz E, Rodeisperger E. Skin and soft tissue infections, in Schillinger D, Harwood-Nuss A, eds. Infections in Emergency Medicine. New York, Churchill Livingstone, 1990, vol 2, pp 63-113.
16. Kerr J. Current topics in tetanus. Intensive Care Med 1979;5:105-110.
17. Erdmann G, Wiegand H, Wellhoner HH. Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus. Naunyn Schmiede-bergs Arch Pharmacol 1975;290:357-373.
18. Trujillo MH, Castillo A, Espana J, et al. Impact of intensive care management of the prognosis of tetanus. Chest 1987;92:63-65. (Pubitemid 17101337)
19. Wright DK, Lalloo UG, Nayiager S, et al. Autonomic nervous system dysfunction in severe tetanus: current perspectives. Crit Care Med 1989;17: 371-375. (Pubitemid 19108372)
20. Edlich RF, Silloway KA, Haines PC, et al. Tetanus. Compr Ther 1986;12: 12-21. (Pubitemid 16081122)
21. Benett J, Azhar N, Rahim F, et al. Further observations on ghee as a risk factor for neonatal tetanus. Int J Epidemiol 1995;24:643-647.
22. Parashar UD, Bennett JV, Boring JR, et al. Topical antimicrobials applied to the umbilical cord stump: a new intervention against neonatal tetanus. Int J Epidemiol 1998;27:904-908. (Pubitemid 28504982)
23. Bennett JV, Schooley M, Traverso HP, et al. A newly identified risk factor for neonatal tetanus: implications for global control. Int J Epidemiol 1996:25:879-884. (Pubitemid 26290075)
24. Tetanus. In: Epidemiology and Prevention of Vaccine-Preventable Diseases. The Pink Book. 11th ed. Atlanta, GA: National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention; 2009; 273-282.
25. Shannon MW, Borron SW, Burns MJ, et al. Winchester's Clinical Management of Poisoning and Drug Overdose. 4th ed. Philadelphia, PA: Saunders/Elsevier; 2007.
26. Abrutyn E. Tetanus. In: Kasper DL, Fauci AS, Longo DL, et al, eds. Harrison's Infectious Diseases (Specialty Series 17th Edition.). New York: McGraw-Hill Inc, 2010, pp 429-434.
27. Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. Br Med J (Clin Res Ed) 1985;291:648-650. (Pubitemid 15236552)
28. Yen LM, Dao LM, Day NPJ, et al. Management of tetanus: a comparison of penicillin and metronidazole. Presented at the Symposium of Antimicrobial Resistance in Southern Vietnam. Ho Chi Minh City, Vietnam; 1997.
29. Blake P, Feldman R, Buchanan T, et al. Serologic therapy of tetanus in the United States, 1965-1971. JAMA 1976;235:42-44.
30. Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Can we avoid sedation and artificial ventilation? Anaesthesia 1997;52:956-962. (Pubitemid 27455509)
31. Attygalle D, Rodrigo N. Magnesium sulphate for control of spasms in severe tetanus. Anesthesia 1999;54:302-303. (Pubitemid 29126995)
32. Plotkin SA, Orenstein WA, Offit PA. Vaccines. 5th ed. Philadelphia, PA: Saunders/Elsevier; 2008:805-839.
33. Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 yearsVUnited States, 2011. MMWR Morb Mortal Wkly Rep 2011;60:3.
34. Recommended adult immunization schedule: United States, 2009*. Ann Intern Med 2009;150:40-44.
35. Passen E, Andersen B. Clinical tetanus despite a protective level of toxin-neutralizing antibody. JAMA 1986;255:1171-1173. (Pubitemid 16167106)
36. Abrahamian F, Pollack CJ, LoVecchio F, et al. Fatal tetanus in a drug abuser with "protective" antitetanus antibodies. J Emerg Med 2000;18: 189-193. (Pubitemid 30105818)
37. Reed DB, Westneat SC. Exposure risks and tetanus immunization status in farmers ages 50 and over. South Med J 2009:102:251-252.
38. Heath CW Jr, Zusman J, Sherman IL. Tetanus in the United States 1950 to 1960. Am J Public Health 1964:54;769-779.